[Cephroxadine--a new antibiotic. Clinical experience].
Cephroxadine is an orally active cephalosporin of third generation. The most important characteristics are: 1) bacterial cell wall synthesis inhibition during active multiplication; 2) wide spectrum of action, including Gram+ and Gram- bacteria and also penicillinase and beta-lactamase producers; 3) possibility of oral administration, quick assimilation and daily moderate dosage (500 mg/12 h). This antibiotic was tested on 71 patients to prevent and resolve dental pre-and post-operating infections. In all tested cases Cephroxadine was very effective and resolved well symptoms on second day, generally. Moreover no patient had any collateral effect to justify interruption of therapy.
Gherlone
E F
EF
D000293:Adolescent; D000328:Adult; D000368:Aged; D001047:Apicoectomy; D002511:Cephalosporins / Q000627:therapeutic use*; D006801:Humans; D007570:Jaw Cysts / Q000601:surgery; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy*; D010149:Postoperative Pain / Q000188:drug therapy; D015494:Salivary Gland Calculi / Q000601:surgery; D014081:Tooth Extraction
D002511:Cephalosporins
Cefroxadina--un nuovo antibiotico. Sperimentazione clinica.